JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

Home・Akciju saraksts・Definitive Healthcare Corp

Definitive Healthcare Corp

Slēgts

SektorsVeselības aprūpe

2.33 0.87

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.26

Max

2.34

Galvenie mērījumi
By Trading Economics
Ienākumi	-8.5M -18M
Pārdošana	-704K 60M
Peļņas marža	-29.631
Darbinieki	782
EBITDA	-8.7M -209K

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+59.91% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 26. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-44M 254M
Iepriekšējā atvēršanas cena	1.46
Iepriekšējā slēgšanas cena	2.33

Ziņu noskaņojums

By Acuity

50%

147 / 352 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

2.6467 / 2.82 Atbalsts un pretestība

Definitive Healthcare Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 2. febr. 23:52 UTC

Iegādes, apvienošanās, pārņemšana

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2026. g. 2. febr. 23:52 UTC

Iegādes, apvienošanās, pārņemšana

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2026. g. 2. febr. 23:48 UTC

Tirgus saruna

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2026. g. 2. febr. 23:38 UTC

Tirgus saruna

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2026. g. 2. febr. 23:28 UTC

Tirgus saruna

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2026. g. 2. febr. 23:23 UTC

Peļņas

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2026. g. 2. febr. 22:57 UTC

Peļņas

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026. g. 2. febr. 22:22 UTC

Iegādes, apvienošanās, pārņemšana

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2026. g. 2. febr. 22:08 UTC

Tirgus saruna

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2026. g. 2. febr. 21:51 UTC

Peļņas

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026. g. 2. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 2. febr. 21:49 UTC

Peļņas

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2026. g. 2. febr. 21:39 UTC

Peļņas

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026. g. 2. febr. 21:36 UTC

Peļņas

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2026. g. 2. febr. 21:34 UTC

Peļņas

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026. g. 2. febr. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2026. g. 2. febr. 21:23 UTC

Peļņas

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2026. g. 2. febr. 21:19 UTC

Peļņas

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2026. g. 2. febr. 21:17 UTC

Peļņas

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2026. g. 2. febr. 21:17 UTC

Peļņas

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026. g. 2. febr. 21:10 UTC

Peļņas

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2026. g. 2. febr. 21:08 UTC

Peļņas

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2026. g. 2. febr. 21:07 UTC

Peļņas

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2026. g. 2. febr. 21:05 UTC

Peļņas

Palantir Technologies 4Q Net $608.7M >PLTR

2026. g. 2. febr. 21:05 UTC

Peļņas

Palantir Technologies 4Q Rev $1.41B >PLTR

2026. g. 2. febr. 21:05 UTC

Peļņas

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2026. g. 2. febr. 21:05 UTC

Peļņas

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2026. g. 2. febr. 21:05 UTC

Peļņas

Palantir Technologies 4Q Adj EPS 25c >PLTR

2026. g. 2. febr. 21:05 UTC

Peļņas

Palantir Technologies 4Q EPS 24c >PLTR

2026. g. 2. febr. 20:40 UTC

Tirgus saruna

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Salīdzinājums

Cenas izmaiņa

Definitive Healthcare Corp Prognoze

Cenas mērķis

By TipRanks

59.91% augšup

Prognoze 12 mēnešiem

Vidējais 3.71 USD 59.91%

Augstākais 5 USD

Zemākais 2.75 USD

Pamatojoties uz 9 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Definitive Healthcare Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

9 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 9 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Definitive Healthcare Corp — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.6467 / 2.82Atbalsts un pretestība

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

There is one bearish event.

Noskaņojums

By Acuity

147 / 352 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Definitive Healthcare Corp

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.